Gene transfer facilitated by a cellular targeting molecule, reovirus protein σ1

Gene Therapy

Volumn 7, Issue 1, 2000, Pages 61-69

  Wu, Y ^a   Boysun, M J ^a   Csencsits, K L ^a   Pascual, D W ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

NALT; Receptor mediated gene transfer

Indexed keywords

ADHESIN; CELL RECEPTOR; CHLOROQUINE; HYBRID PROTEIN; RECOMBINANT PROTEIN; REOVIRUS PROTEIN 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA PROTEIN COMPLEX; DNA TRANSFECTION; FLUORESCENCE MICROSCOPY; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT; REOVIRUS; VACCINATION;

ANIMALS; CAPSID PROTEINS; GENE TRANSFER TECHNIQUES; GENES, REPORTER; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; MICE; NASAL MUCOSA; RECOMBINANT PROTEINS; REOVIRIDAE; TRANSFORMATION, GENETIC; VIRAL PROTEINS;

ANIMALIA; REOVIRUS SP.; RODENTIA;

EID: 0033978710     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301046     Document Type: Article

References (49)

1. Wu CH, Wilson JM, Wu GY. Targeting genes: delivery and persistent expression of foreign gene driven by mammalian regulatory elements in vim. J Biol Chem 1989; 264: 16985-16987.
2. Wu GY et al. Incorporation of adcnovirus into ligand-based DNA carrier system results in retention of original receptor specificity and enhances targeted gene expression. J Biol Chem 1994; 269: 11542-11546.
3. Lozier JN et al. Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes. Hum Gene Ther 1994; 5: 311-322.
4. Wagner E et al. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Prof Natl Acad Sci USA 1990; 87: 3410-3414.
5. Wagner E et al. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhance receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA 1992; 89: 6099-6103.
6. Batra RK et al. Receptor-mediated gene delivery employing lectin-binding specificity. Gene Therapy 1994; 1: 255-260.
7. Leamon CP, Low PS. Membrane folate-binding proteins are responsible for folatc-protein conjugate endocytosis into cultured cells. Biochem J 1993; 291: 855-860.
8. Ross GF et al. Surfactant protein A-polylysine conjugates for delivery of DNA to airway cells in culture Hum Gene Ther 1995; 6: 31-40.
9. Sobolev AS et al. Receptor-mediated transfection of murine and ovine mammary glands in vivo. J Biol Chem 1998; 273: 7928-7933.
10. Chen J, Camou S, Takayanagi A, Shimizu N. A novel gene delivery system using EGF receptor-mediated endocytosis. FEBS Lett 1994; 338: 167-169.
11. Kang Y, Pardridge WM. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidinmonoclonal antibody conjugate. J Pharmacol Exp Therapeul 1994; 269: 344-350.
12. Simon RH et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther 1993; 4: 771-780.
13. Yang Y, Su Q, Wilson JM. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J Virol 1996; 70: 7209-7212.
14. van Cinkcl FW et al. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene. J Immunol 1997; 159: 685-693.
15. Jones BD, Ghori N, Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J Exp Med 1994; 180: 15-23.
16. Lee PWK, Hayes EC, Jolik WK. Protein σ1 is the reovirus cell attachment protein. Virology 1981; 108: 156-163.
17. Mah DC, Leone G, Jankowsiki JM, Lee PW. The N-terminal quarter of reovirus cell attachment protein sigma 1 possesses intrinsic virion-anchoring function. J Virol 1990; 179: 95-103.
18. Bassel-Assel-Duby R et al. Evidence that the sigma1 protein of reovirus serotype 3 is a multimer. J Virol 1987; 61: 1834-1841.
19. Strong JE et al. Biochemical and biophysical characterization of the reovirus cell attachment protein sigmal: evidence that it is a homotrimer. Virology 1991; 184: 23-32.
20. Banerjea AC et al. High-level synthesis of biologically active reovirus protein irl in a mammalian expression vector system. Virology 1988; 167: 601-612.
21. Wolfert MA, Seymour LW. Chloroquine and amphipathic peptide helices show synergistic transfection in vitro. Gene Therapy 1998; 5: 409-414.
22. Spit BJ, Hendriksen EG, Bruijntjes JP, Kuper CF. Nasal lymphoid tissue in the rat. Cell Tiss Res 1989; 255: 193-198.
23. van der Ven I, Sminia T. The development and structure of mouse nasal-associated lymphoid tissue: an immuno-and enzyme-histochemical study. Reg Immunol 1993; 5: 69-75.
24. Rubas W et al. Incorporation of the reovirus M cell attachment protein into small unilamellar vesicles: incorporation efficiency and binding capability to L929 cells in vitro. J Microencap 1990; 7: 385-395.
25. Pappo J, Ermak TH, Steger HJ. Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells. Immunology 1991; 73: 277-280.
26. Zhou F, Kraehenbuhl JP, Neutra MR. Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes. Vaccine 1995; 13: 637-644.
27. Foster N, Clark MA, Jepson MA, Hirst BH. Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vim. Vaccine 1998; 16: 536-541.
28. Paul RW, Lee PW. Glycophorin is the reovirus receptor on human erythrocytes. Virology 1987; 159: 94-101.
29. Weiner HL, Ault KA, Fields BN. Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3. J Immunol 1980; 124: 2143-2148.
30. Wolf JD et al. Intestinal M cells: a pathway for entry of reovirus into the host. Science 1981; 212: 471-472.
31. Nibert ML, Furlong DB, Fields BN. Distinct forms of reovirus and their roles during replication in cells and host. J Clin Invest 1991; 88: 27-34.
32. Weiner HL, Powers ML, Fields BN. Absolute linkage of virulence and central nervous system cell tropism of reovirus to viral hemagglutinin. J Infect Dis 1980; 141: 609-616.
33. Neutra MR, Kraehenbuhl JP. Transepithelial transport and mucosal defence I: the role of M cells. Trends Cell Biol 1992; 2: 134-138.
34. Cotton M et al. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transfcrrin receptor levels. Proc Natl Acad Sci USA 1990; 87: 4033-4037.
35. Curiel DT et al. Gene transfer to respiratory epithelial cells via the receptor-mediated endocytosis pathway. Am J Respir Cell Mol Biol 1992; 6: 247-252.
36. Fynan EF et al. DNA vaccines: protective immunizations by parental, mucosal, and gene gun inoculations. Proc Natl Acad Sci USA 1993; 90: 11478-11482.
37. Robinson HL, Hunt LA, Webster RG. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 1993; 11: 957-960.
38. Gallichan WS, Rosenthal KL. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization. J Infect Dis 1998; 177: 1155-1161.
39. Boyer JD et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Med 1997; 3: 526-532.
40. Boyer JD et al. In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol 1996; 25: 242-250.
41. Herrmann JE et al. Protection against rotavirus infection by DNA vaccination. J Infect Dis 1996; 174 (Suppl. 1): S93-S97.
42. Chen SC et al. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Viral 1998; 72: 5757-5761.
43. Simon MM et al. Protective immunization with plasmid DNA containing the outer membrane surface lipoprotein A gene of Borrelia burgdorferi. Eur J Immunol 1996; 26: 2831-2840.
44. Kuklin N et al. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J Virol 1997; 71: 3138-3145.
45. Jones DH et al. Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine 1997; 15: 814-817.
46. Gregoriadis G, Saffie R, de Souza JB. Liposome-mediated DNA vaccination. FEBS Lett 1997; 402: 107-110.
47. Ishii N et al. Cationic liposome are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1. AIDS Res Hum Retrovir 1997; 13: 1421-1428.
48. Asanuma H et al. Isolation and characterization of mouse nasal-associated lymphoid tissue. J Immunol Meth 1997; 202: 123-131.
49. Heritage PL et al. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches. Am J Respir Crit Care Med 1997; 156 (4 Pt 1): 1256-1262.